Pristane/Hypoxia (PriHx) Mouse as a Novel Model of Pulmonary Hypertension Reflecting Inflammation and Fibrosis-Reference-Cited by-同舟云学术

Pristane/Hypoxia (PriHx) Mouse as a Novel Model of Pulmonary Hypertension Reflecting Inflammation and Fibrosis

Published:2020-06-25 Issue:7 Volume:84 Page:1163-1172
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Mori Hiroyoshi¹²,Ishibashi Tomohiko¹,Inagaki Tadakatsu¹,Okazawa Makoto¹,Masaki Takeshi¹³,Asano Ryotaro¹⁴,Manabe Yusuke¹²,Ohta-Ogo Keiko⁵,Narazaki Masashi²⁶,Ishibashi-Ueda Hatsue⁵,Kumanogoh Atsushi²,Nakaoka Yoshikazu¹³

Affiliation:

1. Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute

2. Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine

3. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

4. Department of Advanced Medical Research for Pulmonary Hypertension, National Cerebral and Cardiovascular Center Research Institute

5. Department of Pathology, National Cerebral and Cardiovascular Center

6. Department of Advanced Clinical and Translational Immunology, Osaka University Graduate School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/84/7/84_CJ-19-1102/_pdf

Reference44 articles.

1. 1. Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 2012; 122: 4306–4313.

2. 2. Stacher E, Graham BB, Hunt JM, Gandjeva A, Groshong SD, McLaughlin VV, et al. Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med 2012; 186: 261–272.

3. 3. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995; 151: 1628–1631.

4. 4. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009; 104: 236–244, 228p following 244.

5. 5. Hashimoto-Kataoka T, Hosen N, Sonobe T, Arita Y, Yasui T, Masaki T, et al. Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension. Proc Natl Acad Sci USA 2015; 112: E2677–E2686.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-6/gp130 signaling in CD4 ⁺ T cells drives the pathogenesis of pulmonary hypertension;Proceedings of the National Academy of Sciences;2024-04-11

2. Repetitive schistosoma exposure causes perivascular lung fibrosis and persistent pulmonary hypertension;Clinical Science;2023-04

3. Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages;Circulation;2022-09-27

4. Text Mining-Based Drug Discovery for Connective Tissue Disease–Associated Pulmonary Arterial Hypertension;Frontiers in Pharmacology;2022-03-18

5. The LPS induced pyroptosis exacerbates BMPR2 signaling deficiency to potentiate SLE‐PAH;The FASEB Journal;2021-11-24